ACLARA BIOSCIENCES INC
10-Q, EX-27.1, 2000-11-14
LABORATORY ANALYTICAL INSTRUMENTS
Previous: ACLARA BIOSCIENCES INC, 10-Q, 2000-11-14
Next: V TWIN HOLDINGS INC, NT 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          95,039
<SECURITIES>                                   103,534
<RECEIVABLES>                                      817
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               162,585
<PP&E>                                           7,749
<DEPRECIATION>                                   1,945
<TOTAL-ASSETS>                                 209,094
<CURRENT-LIABILITIES>                            6,355
<BONDS>                                            624
                                0
                                          0
<COMMON>                                            34
<OTHER-SE>                                     202,003
<TOTAL-LIABILITY-AND-EQUITY>                   209,094
<SALES>                                              0
<TOTAL-REVENUES>                                 2,736
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                28,676
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 487
<INCOME-PRETAX>                               (19,254)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (19,254)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                (1,103)
<CHANGES>                                            0
<NET-INCOME>                                  (20,357)
<EPS-BASIC>                                     (0.61)
<EPS-DILUTED>                                   (0.61)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission